Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF) Research

Sihuan Pharmaceutical Holdings Group Ltd. functions as a diversified investment holding company with a primary focus on the comprehensive lifecycle of pharmaceutical products within mainland China. This includes the research, development, manufacturing, marketing, and distribution of various medicines. The company's extensive drug portfolio addresses significant therapeutic areas, such as oncology (cancer treatment), metabolic disorders, and conditions affecting the digestive system, among others. Beyond its core pharmaceutical business, Sihuan has broadened its operations to encompass the investment in and sale of medical aesthetic products, the production of medical instruments, and strategic real estate investments. Furthermore, it undertakes construction projects for medical facilities and handles the preparatory stages for new pharmaceutical manufacturing initiatives. Its service offerings are equally diverse, including providing information support, operating general hospitals, offering hospital management solutions, promoting biotechnology, and conducting research and development in medical aesthetics. Established in 2001, Sihuan Pharmaceutical is headquartered in Wanchai, Hong Kong.

Open Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.